Modifications in angiotensin II and its antagonistic peptides that should have increased in vivo half-lives but not reduced biological activity were studied by determining the effect of a-methylation of the tyrosine in position 4. angiotensin II, synthesized by the solid-phase procedure, showed 92.6 ± 5.3% pressor activity of angiotensin H. Incubation with a-chymotrypsin for 1 hr indicated absence of degradation although, under the same conditions, angiotensin H was completely degraded to two components. Comparison of the 'H NMR spectra in aqueous solution and the circular dichroism spectra in trifluoroethanol of angiotensin II and [a-methyltyrosine-4]angiotensin II suggested that a methylation of the tyrosine residue in angiotensin HI does not lead to major changes in the overall solution conformation. These results are in contrast to those obtained with N-methylation in position 4, which drastically reduced the biological activity and produced remarkable changes in the peptide backbone and a severe limitation in rotational freedom of the side chains in tyrosine. Thus, it may be possible to synthesize potent angiotensin II analogs that have greater resistance to enzymatic degradation by a-methylation in position 4 (or 5) and simultaneous suitable modification at the NH2 and COOH termini.
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The antagonists for the pressor hormone angiotensin II (AspArg-Val-Tyr-Ile-His-Pro-Phe; All) have proved useful in the study ofexperimental hypertension and as possible new clinical diagnostic tools (1) . However, their long-term application has been limited because they have a short in vivo half-life and, due to degradation by peptidases, are not orally active. We therefore attempted to make these peptides resistant to this enzymatic degradation by replacing the natural amino acid residues with N-methylamino (2) or /3homoamino (3) acid residues. These modifications drastically reduced the biological activity ofthese analogs, and conformation studies suggest that N-methylation in positions 4 or 5 results in remarkable changes in the peptide backbone and a severe limitation in the rotational freedom of the side chains in tyrosine, isoleucine, and histidine residues (4). The replacement ofan a proton by an a methyl group, however, is thought to produce minimal changes in backbone and side-chain structures. The analogs thus obtained might mimic the parent hormone in recognizing and binding with the receptor on the cell membrane and, in addition, be stable to enzymatic degradation (4, 5) . Based on this hypothesis, we have
And, indeed, this peptide is resistant to chymotrypsin degradation and yet retains almost the full pressor activity of All. Conformation studies suggest minimum changes in backbone and side-chain structures. These results again suggest that, for full biological activity (agonist or antagonist), the backbone and side-chain structure of the analog should resemble that of the hormone, All (2, 4) . These observations may be helpful in the design of new potent analogs. 
a-Methyl-L-tyrosine (3.904 g; 20 mmol) and 1.6 g of NaOH (20 mmol) in 10 ml of H20 were treated with 2.5 g of CuSO4-5H20 (10 mmol) in 10 ml of H20. The mixture was shaken on a wrist shaker for 10 min, and 60 ml of MeOH was added, followed by 2.38 ml of C6H5CH2Br (20 mmol). The flask was stoppered, and the mixture was shaken for 20 hr at room temperature. The copper complex was removed by filtration, washed with three 10-ml portions of H20, two 10-ml portions of MeOH, and two 10-ml portions of Et2O. The semi-air-dried product (6.2 g) was suspended in 40 ml of 1 M HCl, pulverized, and filtered out. The precipitate was repeatedly macerated with 1 M HC1 and filtered out until the filtrate was almost colorless. The residue was then stirred with 20 ml of 16.4% AcONa, filtered out, washed with hot water, and dried at reduced pressure over P205. O-Benzyl-a-methyl-L-tyrosine thus obtained was homogeneous: thin layer chromatography (TLC) on silica gel, RF 0.43 in n-BuOH/AcOH/H20 (4:1:5); RF 0.57 in n-PrOH/ H20 (1:1).
tert (5 mmol) in 30 ml of Me2SO was treated with 0.72 ml of NEt3 (5 mmol) and 0. 3 g oftert-butyloxycarbonyl azide (0. 3 g), and the mixture was stirred at 40°C under anhydrous conditions for 24 hr. The addition ofBoc-N3 (0.3 g) and NEt3 (0. 72 ml) was repeated every 24 hr until the solid went into solution (1 week or more). The solution was diluted with 40 ml of H20, treated with NaOH to pH 9, and extracted with three 25-ml portions of Et2O. The aqueous layer was evaporated to dryness at 20°C at reduced pressure on a rotary evaporator. The residue was dissolved in 7 ml ofH20, and the solution was cooled to 0°C and treated with ice-cold citric acid solution to pH 4.5. The solution was then saturated with solid NaCl and extracted with AcOEt; the organic phase was washed with H20 and then with saturated NaCl solution, dried with Na2SO4, and evaporated to yield 2 The publication costs ofthis article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. §1734 solely to indicate this fact.
product: TLC on silica gel,RF0.67 in EtOH; RF0.81 in CHC13/ AcOH (95:5); RF0.73 in CHClJMeOH/AcOH (85:10:5).
[a-MeTyr4]AII. COOH-Terminal tert-butyloxycarbonyl-Lphenylalanine was attached to 2% crosslinked chloromethyl polymer as described, and chain elongation was performed on a manual nitrogen-stirred apparatus (6) by using the protocol described (7) . In general, the coupling reaction was carried out twice for 6-12 hr each time. 1-Hydroxybenzotriazole (2 mmol per mmol of tert-butyloxycarbonylamino acid) was used as an additive during coupling with N,N-dicyclohexylcarbodiimide. Apart from facilitating the coupling reaction, this procedure also avoids racemization of the histidine residue during coupling with tert-butyloxycarbonyl-Nim-benzylhistidine (8) . Coupling with tert-butyloxycarbonylvaline was difficult and was repeated three times by using a 3-fold excess of this derivative and a 6-fold excess of 1-hydroxybenzotriazole each time. At the end of the synthesis, the peptide was removed from the polymer with HBr/CF3COOH and hydrogenated over 5% palladium/BaSO4 in MeOH/AcOH/H20 (5:1:1). The crude product was purified on a column of Bio-Rad anion exchange resin (AG-1 X 2, 200-400 mesh, acetate form) by eluting with ammonium acetate buffer (pH 8.5). Fractions containing the major component were pooled, lyophilized, and rechromatographed on successive columns of Sephadex G-25 by using n-BuOH/pyridine/ H20 (65:35:35, upper phase) and n-BuOH/AcOH/H20 ( Enzymatic Degradation with a-Chymotrypsin. Incubation of the peptide solution (0.1 M ammonium acetate buffer, pH 8.5) with chymotrypsin (beef pancreas, triple crystallized) (3) for 1 hr followed by TLC indicated the absence of degradation products when the chromatogram was sprayed with ninhydrin. Under the same conditions, angiotensin II was completely degraded into two components (presumably tetrapeptides).
'H NMR. The peptides All and [a-MeTyr4]AII were studied under identical conditions-0.01 M in the cationic state in deuterated dimethyl sulfoxide. Tetramethylsilane was used as internal reference. 'H NMR spectra were obtained on 250-MHz and 400-MHz instruments. Signal assignment was carried out on the basis of double resonance experiments and by comparison with previous work (10) . Circular Dichroism (CD). CD spectra were recorded on a Dichrograph model III (Jobin Yvon) using fused quartz cells of 1.0-cm and 0.01-cm path length. The results are expressed in molar ellipticity, and pH titrations were carried out as described (11) . RESULTS 'H NMR. In addition to the conformational information that can be extracted from the 'H NMR spectrum, one can ascertain the correct chemical nature of the analog studied. Comparison of the spectrum of[a-MeTyr4]AII with that of All shows (i) the appearance of a methyl group single peak at 1.31 ppm; (ii) the disappearance of the tyrosine a-proton octuplet (4.52 ppm in All), (iii) the transformation of the amide proton doublet of tyrosine (8.07 ppm in All) into a single peak at 7.47 ppm; (iv) an upfield shift of the aromatic meta protons of tyrosine (0.26 ppm with respect to All); and (v) that all the other a-protons exhibit the same chemical shifts and patterns as in the native peptide (Fig. 1) . These data leave no doubt as to the correct chemical structure of the peptide [a-MeTyr4]AII.
The majority of the proton resonances are identical in All and la-MeTyr4]AII, but differences in the chemical shifts are detected on the NH and sidechain protons of the tyrosine-neighbor residues valine-3 and isoleucine-5. It is reasonable to attribute these differences to the inductive effect of the a-methyl group and to a slight reorientation and decrease of rotational properties of the tyrosine side chain (ring-current effects).
Two types of conformationally related vicinal coupling con- [Asp',Val5]AII and All. As to the rotamer distribution of the principal side chains of All, a parameter that is sensitive to overall or local conformational changes (4 and 4i angles), no significant difference exists between the two peptides (12) . 'H NMR spectra ofpeptides in dimethyl sulfoxide also permit the observation of temperature effects on the NH proton chemical shifts that can be related to overall conformational stability and internal hydrogen bonding. The slopes of the temperaturedependence curves of the NH protons in [a-MeTyr4]AII are generally less pronounced than those in All, which suggests that the a-methylation of the pivotal tyrosine residue has slightly increased the global rigidity in the peptide backbone.
Circular Dichroism. CD has been shown to be a very sensitive method for monitoring even small conformational changes in peptides and proteins (4, 10, 11) . With respect to the All peptides, the CD spectrum in the peptide region of [aMeTyr4]AII in trifluoroethanol, and a pH titration curve of the tyrosine 'Lb and at 275 nm in aqueous solution, have been shown to respond readily to global or local structural changes, respectively. The CD spectrum of [a-MeTyr4]AII in TFE, recorded at 250-180 nm consists essentially of two bands, a negative one at 225 nm and a positive one at 195 nm, consistent with the antiparallel ,B-sheet conformation and practically identical to that of All in the same solvent (13) . The intensities ofthe two bands are somewhat higher in the a-methylated analog, however, again suggesting greater stability in and around position 4 of the backbone (Fig. 2) . In aqueous solution, the CD spectrum of the aromatic region is also identical in shape to that of All, albeit of slightly higher intensity at 275 nm. Just as in All, titration of the carboxyl group (the positive slope has been shown to be due to the influence of the aspartic acid j3-carboxyl (15, 16) . a-Aminoisobutyric acid has been found in the C7 conformation both in solution (15) Considering the ever stronger correlation between the conformation and the biological activity ofAII peptides, it is logical to predict full biological activity for [a-MeTyr4]AII. As a-methylation of the tyrosine residue practically eliminates the susceptibility of the peptide to chymotryptic hydrolysis, the synthesis of further analogs of this type (which conserve the essential conformation while being resistant to enzymatic attack) can be expected. In addition to a-methylation in position 4 (or 5) , suitable modifications at the NH2 and COOH termini are necessary to stabilize these peptides against enzymatic attack by endopeptidases and exopeptidases.
